Literature DB >> 13180832

Treatment of schistosomiasis mansoni with antimony-omega, omega-dimercapto-potassium succinate (TWSb).

E A FRIEDHEIM, J R DA SILVA, A V MARTINS.   

Abstract

Entities:  

Keywords:  ANTIMONY/therapeutic use; SCHISTOSOMIASIS/prevention and control

Mesh：

Substances：

Year:  1954        PMID： 13180832     DOI： 10.4269/ajtmh.1954.3.714

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  7 in total

1.  Electrocardiographic effects of antimony dimercapto-succinate ('astiban').

Authors:  K SOMERS; J D ROSANELLI
Journal:  Br Heart J       Date:  1962-03

2.  The effect of antimony dimercapto-succinate on the electrocardiogram.

Authors:  A DAVIS
Journal:  Br Heart J       Date:  1961-05

3.  Treatment of intestinal bilharziasis with antimonials: the possible use of dimercaprol as an adjuvant to therapy.

Authors:  M T Khayyal
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

4.  Lead poisoning: case studies.

Authors:  J N Gordon; A Taylor; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

Review 5.  The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.

Authors:  D E Glotzer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 6.  Arsenic Toxicity: Molecular Targets and Therapeutic Agents.

Authors:  Valeria M Nurchi; Aleksandra Buha Djordjevic; Guido Crisponi; Jan Alexander; Geir Bjørklund; Jan Aaseth
Journal:  Biomolecules       Date:  2020-02-04

Review 7.  Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.

Authors:  J J Chisolm
Journal:  Environ Health Perspect       Date:  1990-11       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.